Steven Cohen Silverback Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
N/A
5,238 New
5,238 $0
Q3 2021

Nov 15, 2021
SELL
$9.98 - $35.22 $1.93 Million - $6.8 Million
-192,996 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$24.71 - $44.28 $2.34 Million - $4.19 Million
-94,604 Reduced 32.89%
192,996 $5.96 Million
Q1 2021

May 17, 2021
BUY
$37.62 - $60.41 $10.8 Million - $17.4 Million
287,600 New
287,600 $12.5 Million

Others Institutions Holding SBTX

# of Institutions
163
Shares Held
62.7M
Call Options Held
872K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email